US Stock MarketDetailed Quotes

DNTH Dianthus Therapeutics

Watchlist
  • 20.430
  • -0.340-1.64%
Trading Nov 21 13:45 ET
604.67MMarket Cap-8940P/E (TTM)

Dianthus Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-112.84%-21.27M
-207.08%-14.53M
-45.28%-14.94M
-26.80%-36.86M
-33.93%-11.85M
-9.99M
-4.73M
-10.28M
-193.52%-29.07M
-8.85M
Net income from continuing operations
-70.52%-25.17M
-58.05%-17.61M
-93.93%-13.75M
-52.95%-43.56M
-4.42%-10.56M
---14.76M
---11.14M
---7.09M
-117.22%-28.48M
---10.12M
Depreciation and amortization
33.33%116K
32.14%111K
32.10%107K
141.50%355K
110.20%103K
--87K
--84K
--81K
--147K
--49K
Change In working capital
-32.23%2.6M
-95.24%289K
18.37%-2.82M
394.13%4.86M
-244.16%-1.59M
--3.84M
--6.07M
---3.45M
-152.61%-1.65M
--1.11M
-Change in receivables
-3,575.86%-1.01M
-121.64%-799K
-134.13%-398K
223.98%5.16M
123.70%273K
--29K
--3.69M
--1.17M
-181.98%-4.16M
---1.15M
-Change in prepaid assets
-120.00%-378K
-153.89%-291K
107.76%241K
119.49%123K
-1,148.92%-2.42M
--1.89M
--540K
--116K
-132.84%-631K
--231K
-Change in payables and accrued expense
631.05%5.65M
7.70%3.25M
36.86%-2.99M
-71.01%661K
-21.07%1.6M
--773K
--3.01M
---4.73M
-53.65%2.28M
--2.03M
-Change in other current assets
-81,100.00%-1.62M
-26,242.86%-1.83M
6,760.00%343K
-3,212.90%-1.03M
-5,861.11%-1.04M
---2K
--7K
--5K
-3.33%-31K
--18K
-Change in other working capital
-103.67%-42K
96.87%-37K
-88.89%-17K
-106.17%-55K
60.87%-9K
--1.15M
---1.18M
---9K
--891K
---23K
Cash from discontinued investing activities
Operating cash flow
-112.84%-21.27M
-207.08%-14.53M
-45.28%-14.94M
-26.80%-36.86M
-33.93%-11.85M
---9.99M
---4.73M
---10.28M
-193.52%-29.07M
---8.85M
Investing cash flow
Cash flow from continuing investing activities
-2,154.36%-259.36M
-94.65%1.17M
-130.37%-5.51M
133.86%20.25M
34.96%-8.24M
-11.51M
21.86M
18.13M
-181,169.70%-59.82M
-12.67M
Capital expenditure reported
61.54%-25K
19.05%-17K
-128.57%-32K
20.86%-110K
65.52%-10K
---65K
---21K
---14K
-321.21%-139K
---29K
Net investment purchase and sale
-2,166.95%-259.34M
-94.58%1.19M
-130.17%-5.48M
134.12%20.36M
34.89%-8.23M
---11.44M
--21.89M
--18.15M
---59.68M
---12.64M
Cash from discontinued investing activities
Investing cash flow
-2,154.36%-259.36M
-94.65%1.17M
-130.37%-5.51M
133.86%20.25M
34.96%-8.24M
---11.51M
--21.86M
--18.13M
-181,169.70%-59.82M
---12.67M
Financing cash flow
Cash flow from continuing financing activities
-99.79%296K
-2.2M
217.85M
38.17%133.57M
-4.87M
138.44M
0
0
548.31%96.68M
0
Net issuance payments of debt
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Net common stock issuance
--0
--0
--230M
--72M
--0
--72M
--0
--0
--0
--0
Net preferred stock issuance
----
----
----
--0
----
----
----
----
566.67%100M
--0
Proceeds from stock option exercised by employees
5,820.00%296K
--47K
--271K
--5K
--0
--5K
--0
--0
--0
--0
Net other financing activities
--0
---2.24M
---12.42M
1,952.26%61.57M
---4.87M
----
----
----
-3,677.27%-3.32M
--0
Cash from discontinued financing activities
Financing cash flow
-99.79%296K
---2.2M
--217.85M
38.17%133.57M
---4.87M
--138.44M
--0
--0
548.31%96.68M
--0
Net cash flow
Beginning cash position
677.71%314.24M
1,317.11%329.79M
758.29%132.39M
101.95%15.43M
325.94%157.35M
--40.41M
--23.27M
--15.43M
186.82%7.64M
--36.94M
Current changes in cash
-339.72%-280.34M
-190.79%-15.56M
2,415.60%197.4M
1,402.07%116.97M
-15.99%-24.96M
--116.94M
--17.13M
--7.85M
56.52%7.79M
---21.52M
End cash Position
-78.46%33.9M
677.71%314.24M
1,317.11%329.79M
758.29%132.39M
758.29%132.39M
--157.35M
--40.41M
--23.27M
101.95%15.43M
--15.43M
Free cash flow
-111.71%-21.29M
-206.08%-14.55M
-45.40%-14.97M
-26.57%-36.97M
-33.60%-11.86M
---10.06M
---4.75M
---10.3M
-193.94%-29.21M
---8.88M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -112.84%-21.27M-207.08%-14.53M-45.28%-14.94M-26.80%-36.86M-33.93%-11.85M-9.99M-4.73M-10.28M-193.52%-29.07M-8.85M
Net income from continuing operations -70.52%-25.17M-58.05%-17.61M-93.93%-13.75M-52.95%-43.56M-4.42%-10.56M---14.76M---11.14M---7.09M-117.22%-28.48M---10.12M
Depreciation and amortization 33.33%116K32.14%111K32.10%107K141.50%355K110.20%103K--87K--84K--81K--147K--49K
Change In working capital -32.23%2.6M-95.24%289K18.37%-2.82M394.13%4.86M-244.16%-1.59M--3.84M--6.07M---3.45M-152.61%-1.65M--1.11M
-Change in receivables -3,575.86%-1.01M-121.64%-799K-134.13%-398K223.98%5.16M123.70%273K--29K--3.69M--1.17M-181.98%-4.16M---1.15M
-Change in prepaid assets -120.00%-378K-153.89%-291K107.76%241K119.49%123K-1,148.92%-2.42M--1.89M--540K--116K-132.84%-631K--231K
-Change in payables and accrued expense 631.05%5.65M7.70%3.25M36.86%-2.99M-71.01%661K-21.07%1.6M--773K--3.01M---4.73M-53.65%2.28M--2.03M
-Change in other current assets -81,100.00%-1.62M-26,242.86%-1.83M6,760.00%343K-3,212.90%-1.03M-5,861.11%-1.04M---2K--7K--5K-3.33%-31K--18K
-Change in other working capital -103.67%-42K96.87%-37K-88.89%-17K-106.17%-55K60.87%-9K--1.15M---1.18M---9K--891K---23K
Cash from discontinued investing activities
Operating cash flow -112.84%-21.27M-207.08%-14.53M-45.28%-14.94M-26.80%-36.86M-33.93%-11.85M---9.99M---4.73M---10.28M-193.52%-29.07M---8.85M
Investing cash flow
Cash flow from continuing investing activities -2,154.36%-259.36M-94.65%1.17M-130.37%-5.51M133.86%20.25M34.96%-8.24M-11.51M21.86M18.13M-181,169.70%-59.82M-12.67M
Capital expenditure reported 61.54%-25K19.05%-17K-128.57%-32K20.86%-110K65.52%-10K---65K---21K---14K-321.21%-139K---29K
Net investment purchase and sale -2,166.95%-259.34M-94.58%1.19M-130.17%-5.48M134.12%20.36M34.89%-8.23M---11.44M--21.89M--18.15M---59.68M---12.64M
Cash from discontinued investing activities
Investing cash flow -2,154.36%-259.36M-94.65%1.17M-130.37%-5.51M133.86%20.25M34.96%-8.24M---11.51M--21.86M--18.13M-181,169.70%-59.82M---12.67M
Financing cash flow
Cash flow from continuing financing activities -99.79%296K-2.2M217.85M38.17%133.57M-4.87M138.44M00548.31%96.68M0
Net issuance payments of debt --0--0--0--0--0--0--0--0--0--0
Net common stock issuance --0--0--230M--72M--0--72M--0--0--0--0
Net preferred stock issuance --------------0----------------566.67%100M--0
Proceeds from stock option exercised by employees 5,820.00%296K--47K--271K--5K--0--5K--0--0--0--0
Net other financing activities --0---2.24M---12.42M1,952.26%61.57M---4.87M-------------3,677.27%-3.32M--0
Cash from discontinued financing activities
Financing cash flow -99.79%296K---2.2M--217.85M38.17%133.57M---4.87M--138.44M--0--0548.31%96.68M--0
Net cash flow
Beginning cash position 677.71%314.24M1,317.11%329.79M758.29%132.39M101.95%15.43M325.94%157.35M--40.41M--23.27M--15.43M186.82%7.64M--36.94M
Current changes in cash -339.72%-280.34M-190.79%-15.56M2,415.60%197.4M1,402.07%116.97M-15.99%-24.96M--116.94M--17.13M--7.85M56.52%7.79M---21.52M
End cash Position -78.46%33.9M677.71%314.24M1,317.11%329.79M758.29%132.39M758.29%132.39M--157.35M--40.41M--23.27M101.95%15.43M--15.43M
Free cash flow -111.71%-21.29M-206.08%-14.55M-45.40%-14.97M-26.57%-36.97M-33.60%-11.86M---10.06M---4.75M---10.3M-193.94%-29.21M---8.88M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data